SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-23-013182
Filing Date
2023-10-20
Accepted
2023-10-20 06:06:21
Documents
14
Period of Report
2023-10-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K biocept_8k.htm   iXBRL 8-K 28479
  Complete submission text file 0001654954-23-013182.txt   149831

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA biocept-20231016.xsd EX-101.SCH 5744
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE biocept-20231016_lab.xml EX-101.LAB 14114
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE biocept-20231016_cal.xml EX-101.CAL 907
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biocept-20231016_pre.xml EX-101.PRE 8916
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE biocept-20231016_def.xml EX-101.DEF 2108
8 EXTRACTED XBRL INSTANCE DOCUMENT biocept_8k_htm.xml XML 3483
Mailing Address 9955 MESA RIM ROAD SAN DIEGO CA 92121
Business Address 9955 MESA RIM ROAD SAN DIEGO CA 92121 858-320-8200
BIOCEPT INC (Filer) CIK: 0001044378 (see all company filings)

IRS No.: 800943522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36284 | Film No.: 231335913
SIC: 8071 Services-Medical Laboratories